Disclosure Information2026-10-23 04:48:40 (KST)
No Date Title Submitter
53 2026/09/29 Foreign Corporation, etc. : Report on Appointment or Dismissal or Change of External Auditor Prestige BioPharma Limited
52 2026/09/29 Outcome of Annual Shareholders' Meeting Prestige BioPharma Limited
51 2026/09/29 Report on the Appointment, Dismissal or Early Retirement of Independent Directors Prestige BioPharma Limited
50 2026/09/23 [Corrected description]Annual Report (2026.06) Prestige BioPharma Limited
49 2026/09/22 Annual Report (2026.06) Prestige BioPharma Limited
48 2026/09/21 Submission of Audit Report Prestige BioPharma Limited
47 2026/09/14 Decision on Calling Shareholders' Meeting Prestige BioPharma Limited
46 2026/09/14 Announcement of convocation of general meeting of shareholders Prestige BioPharma Limited
45 2026/09/01 Report on Shares Change of Largest Shareholders Prestige BioPharma Limited
44 2026/09/01 Report on status of specific securities, etc. owned by executives and major shareholders Prestige BioPharma Limited
43 2026/09/01 Report on significant holdings of stocks, etc. (General) Prestige BioPharma Limited
42 2026/08/25 [Corrected description]Conclusion of Single Sales Contract or Supply Contract Prestige BioPharma Limited
41 2026/08/19 Report on Shares Change of Largest Shareholders Prestige BioPharma Limited
40 2026/08/19 Report on significant holdings of stocks, etc. (General) Prestige BioPharma Limited
39 2026/08/19 Report on status of specific securities, etc. owned by executives and major shareholders Prestige BioPharma Limited